These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25529309)

  • 1. Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': the ACTIVE Dialysis Study.
    Jardine MJ; Zuo LI; Gray NA; de Zoysa J; Chan CT; Gallagher MP; Howard K; Hertier S; Cass A; Perkovic V;
    Nephrology (Carlton); 2015 Apr; 20(4):257-65. PubMed ID: 25529309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study.
    Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Hawley CM; Isbel NM; Krum H; Pascoe EM; Tonkin AM; Vergara LA; Perkovic V;
    Nephrology (Carlton); 2015 Mar; 20(3):140-7. PubMed ID: 25382452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and protocol for the Dialysis Optimal Health Program (DOHP) randomised controlled trial.
    Knowles SR; Ski CF; Langham R; O'Flaherty E; Thompson DR; Rossell SL; Moore G; Hsueh YS; Castle DJ
    Trials; 2016 Sep; 17(1):447. PubMed ID: 27612446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of initiating dialysis early: a randomized controlled trial.
    Harris A; Cooper BA; Li JJ; Bulfone L; Branley P; Collins JF; Craig JC; Fraenkel MB; Johnson DW; Kesselhut J; Luxton G; Pilmore A; Rosevear M; Tiller DJ; Pollock CA; Harris DC
    Am J Kidney Dis; 2011 May; 57(5):707-15. PubMed ID: 21349618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Trial of Extending Hemodialysis Hours and Quality of Life.
    Jardine MJ; Zuo L; Gray NA; de Zoysa JR; Chan CT; Gallagher MP; Monaghan H; Grieve SM; Puranik R; Lin H; Eris JM; Zhang L; Xu J; Howard K; Lo S; Cass A; Perkovic V; ;
    J Am Soc Nephrol; 2017 Jun; 28(6):1898-1911. PubMed ID: 28151412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of extended hours dialysis on sleep quality in a randomized trial.
    Liao JL; van den Broek-Best O; Smyth B; Hong D; Vo K; Zuo L; Gray NA; Chan CT; de Zoysa J; Perkovic V; Jiang L; Jardine M
    Nephrology (Carlton); 2019 Apr; 24(4):430-437. PubMed ID: 29424935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment and participant baseline characteristics in the dialysis outcomes in those aged 65 years or older study.
    McNoe B; Schollum JBW; Derrett S; Marshall MR; Henderson A; Samaranayaka A; Walker RJ
    BMC Nephrol; 2019 Apr; 20(1):137. PubMed ID: 31014261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.
    Garg AX; Suri RS; Eggers P; Finkelstein FO; Greene T; Kimmel PL; Kliger AS; Larive B; Lindsay RM; Pierratos A; Unruh M; Chertow GM;
    Kidney Int; 2017 Mar; 91(3):746-754. PubMed ID: 28094031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.
    Wang W; Tonelli M; Hemmelgarn B; Gao S; Johnson JA; Taub K; Manns B;
    Am J Kidney Dis; 2008 May; 51(5):796-803. PubMed ID: 18436090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial].
    Saglimbene V; D'Alonzo D; Ruospo M; Vecchio M; Natale P; Gargano L; Nicolucci A; Pellegrini F; Craig JC; Triolo G; Procaccini DA; Santoro A; Di Giulio S; La Rosa S; Murgo A; Di Toro Mammarella R; Sambati M; D'Ambrosio N; Greco V; Giannoccaro G; Flammini A; Boccia E; Montalto G; Pagano S; Amarù S; Fici M; Lumaga GB; Mancini E; Veronesi M; Patregnani L; Querques M; Schiavone P; Chimienti S; Palumbo R; Di Franco D; Della Volpe M; Gori E; Salomone M; Iacono A; Moscoloni M; Treglia A; Casu D; Piras AM; Di Silva A; Mandreoli M; Lopez A; Quarello F; Catizone L; Russo G; Forcellini S; Maccarone M; Catucci G; Di Paolo B; Stingone A; D'Angelo B; Guastoni C; Pasquali S; Minoretti C; Bellasi A; Boscutti G; Martone M; David S; Schito F; Urban L; Di Iorio B; Caruso F; Mazzoni A; Musacchio R; Andreoli D; Cossu M; Li Cavoli G; Cornacchiari M; Granata A; Clementi A; Giordano R; Guastoni C; Barzaghi W; Valentini M; Hegbrant J; Tognoni G; Strippoli GF
    G Ital Nefrol; 2013; 30(2):. PubMed ID: 23832463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet.
    Belozeroff V; Lee A; Tseng S; Chiroli S; Campbell JD
    J Med Econ; 2013 Sep; 16(9):1154-62. PubMed ID: 23869940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study.
    Lamping DL; Constantinovici N; Roderick P; Normand C; Henderson L; Harris S; Brown E; Gruen R; Victor C
    Lancet; 2000 Nov; 356(9241):1543-50. PubMed ID: 11075766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodialysis: hospital or home?
    Power A; Ashby D
    Postgrad Med J; 2014 Feb; 90(1060):92-7. PubMed ID: 24222691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial.
    Fernández Lucas M; Ruíz-Roso G; Merino JL; Sánchez R; Bouarich H; Herrero JA; Muriel A; Zamora J; Collado A
    Trials; 2020 Feb; 21(1):206. PubMed ID: 32075665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial.
    Smyth B; Zuo L; Gray NA; Chan CT; de Zoysa JR; Hong D; Rogers K; Wang J; Cass A; Gallagher M; Perkovic V; Jardine M;
    Nephrology (Carlton); 2020 Oct; 25(10):792-800. PubMed ID: 32500957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
    Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varying Association of Extended Hours Dialysis with Quality of Life.
    Smyth B; van den Broek-Best O; Hong D; Howard K; Rogers K; Zuo L; Gray NA; de Zoysa JR; Chan CT; Lin H; Zhang L; Xu J; Cass A; Gallagher M; Perkovic V; Jardine M
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1751-1762. PubMed ID: 31672793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the effects of 6 months extended duration, in-centre nocturnal versus conventional haemodialysis treatment: a non-randomised, controlled feasibility study.
    Churchward DR; Graham-Brown MP; Preston R; Pickering W; McCann GP; Burton JO
    BMJ Open; 2016 Sep; 6(9):e012583. PubMed ID: 27609856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A crossover study of short daily haemodialysis.
    Goldfarb-Rumyantzev AS; Leypoldt JK; Nelson N; Kutner NG; Cheung AK
    Nephrol Dial Transplant; 2006 Jan; 21(1):166-75. PubMed ID: 16169869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.